Arab East Investment Company PLC (ASE:AEIV)

Ligand Pharmaceuticals Balance Sheet

Financials in millions JOD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.67	0.63	0.79	1.13	1.21	1.47
Short-Term Investments	-	-	-	-	-	0.92
Trading Asset Securities	1.24	1.34	1.84	1.91	1.9	0.12
Cash & Short-Term Investments	1.92	1.97	2.63	3.04	3.12	2.51
Cash Growth	4.26%	-25.30%	-13.40%	-2.47%	24.13%	24.82%
Accounts Receivable	-	0.82	1.77	1.77	1.77	1.78
Other Receivables	1.27	-	-	-	-	-
Receivables	1.27	0.82	1.77	1.77	1.77	1.78
Inventory	6.06	6.28	6.67	6.76	7.21	7.66
Other Current Assets	-	0.48	0.06	0.07	0.06	0.17
Total Current Assets	9.25	9.55	11.13	11.64	12.17	12.12
Property, Plant & Equipment	0	0	0	0	0	0.04
Long-Term Investments	14.15	14.17	14.41	13.53	13.88	13.07
Other Long-Term Assets	37.65	37.71	37.89	38.07	38.22	38.19
Total Assets	61.05	61.43	63.43	63.24	64.27	63.42
Accounts Payable	-	0.19	0.19	0.24	0.22	0.2
Current Portion of Long-Term Debt	0.1	0.05	0.33	0.53	0.61	0.7
Current Portion of Leases	-	0	-	-	-	-
Current Income Taxes Payable	-	0.02	0.02	0.03	0.02	0
Current Unearned Revenue	-	0.01	0.01	0.03	0.04	0.05
Other Current Liabilities	0.7	0.5	0.57	0.61	0.75	0.81
Total Current Liabilities	0.8	0.78	1.12	1.44	1.64	1.76
Long-Term Debt	2.45	2.5	2.6	2.85	3.34	3.43
Long-Term Unearned Revenue	0.07	0.07	0.07	0.07	0.07	0.07
Other Long-Term Liabilities	7.25	7.24	7.24	7.25	7.25	7.24
Total Liabilities	10.57	10.59	11.04	11.61	12.3	12.5
Common Stock	47	47	47	47	47	47
Retained Earnings	8.05	8.58	10.07	10.04	10.53	9.81
Treasury Stock	-4.97	-4.97	-4.99	-5.01	-5.01	-5.01
Comprehensive Income & Other	0.2	0.04	0.12	-0.6	-0.74	-1.07
Total Common Equity	50.28	50.65	52.2	51.43	51.78	50.74
Minority Interest	0.19	0.19	0.2	0.19	0.19	0.19
Shareholders' Equity	50.47	50.84	52.39	51.62	51.97	50.92
Total Liabilities & Equity	61.05	61.43	63.43	63.24	64.27	63.42
Total Debt	2.55	2.56	2.93	3.38	3.95	4.13
Net Cash (Debt)	-0.64	-0.59	-0.3	-0.34	-0.83	-1.62
Net Cash Per Share	-0.01	-0.01	-0.01	-0.01	-0.02	-0.04
Filing Date Shares Outstanding	44.98	42.7	44.56	45.06	43	47.82
Total Common Shares Outstanding	44.98	42.7	44.56	45.06	43	47.82
Working Capital	8.45	8.77	10.01	10.2	10.53	10.36
Book Value Per Share	1.12	1.19	1.17	1.14	1.20	1.06
Tangible Book Value	50.28	50.65	52.2	51.43	51.78	50.74
Tangible Book Value Per Share	1.12	1.19	1.17	1.14	1.20	1.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.